Steven A Greenstein1, Kristen L Fry, Matthew J Hersh, Peter S Hersh. 1. Cornea and Laser Eye Institute-Hersh Vision Group, CLEI Center for Keratoconus, Teaneck, and Department of Ophthalmology, UMDNJ-New Jersey Medical School, Newark, New Jersey 07666, USA.
Abstract
PURPOSE: To determine changes in higher-order aberrations (HOAs) after corneal collagen crosslinking (CXL). SETTING: Cornea and refractive surgery practice. DESIGN: Prospective randomized controlled clinical trial. METHODS:Corneal and ocular HOAs were measured and analyzed using the Pentacam device and Ladarwave aberrometer, respectively, at baseline and 12 months after CXL. RESULTS:Ninety-six eyes (64 keratoconus, 32 ectasia) of 73 patients had CXL. A fellow-eye control group comprised 42 eyes. The mean preoperative total anterior corneal HOAs, total coma, 3rd-order coma, and vertical coma were 4.68 μm ± 2.33 (SD), 4.40 ± 2.32 μm, 4.36 ± 2.30 μm, and 4.04 ± 2.27 μm, respectively. At 1 year, the mean values decreased significantly to 4.27 ± 2.25 μm, 4.01 ± 2.29 μm, 3.96 ± 2.27 μm, and 3.66 ± 2.22 μm, respectively (all P<.001). There were no significant changes in posterior corneal HOAs. The mean preoperative total ocular HOAs, total coma, 3rd-order coma, trefoil, and spherical aberration were 2.80 ± 1.0 μm, 2.60 ± 1.03 μm, 2.57 ± 1.03 μm, 0.98 ± 0.46 μm, and 0.90 ± 0.42 μm, respectively. At 1 year, the mean values decreased significantly to 2.59 ± 1.06 μm, 2.42 ± 1.07 μm, 2.39 ± 1.07 μm, 0.88 ± 0.49 μm, and 0.83 ± 0.38 μm, respectively (all P=.01). After CXL, HOAs were significantly improved compared with the control group. Changes in HOAs were not statistically associated with an improvement in visual acuity or most subjective visual symptoms, however. CONCLUSION:Corneal and ocular HOAs decreased after CXL, suggesting an improvement in corneal shape.
RCT Entities:
PURPOSE: To determine changes in higher-order aberrations (HOAs) after corneal collagen crosslinking (CXL). SETTING: Cornea and refractive surgery practice. DESIGN: Prospective randomized controlled clinical trial. METHODS: Corneal and ocular HOAs were measured and analyzed using the Pentacam device and Ladarwave aberrometer, respectively, at baseline and 12 months after CXL. RESULTS: Ninety-six eyes (64 keratoconus, 32 ectasia) of 73 patients had CXL. A fellow-eye control group comprised 42 eyes. The mean preoperative total anterior corneal HOAs, total coma, 3rd-order coma, and vertical coma were 4.68 μm ± 2.33 (SD), 4.40 ± 2.32 μm, 4.36 ± 2.30 μm, and 4.04 ± 2.27 μm, respectively. At 1 year, the mean values decreased significantly to 4.27 ± 2.25 μm, 4.01 ± 2.29 μm, 3.96 ± 2.27 μm, and 3.66 ± 2.22 μm, respectively (all P<.001). There were no significant changes in posterior corneal HOAs. The mean preoperative total ocular HOAs, total coma, 3rd-order coma, trefoil, and spherical aberration were 2.80 ± 1.0 μm, 2.60 ± 1.03 μm, 2.57 ± 1.03 μm, 0.98 ± 0.46 μm, and 0.90 ± 0.42 μm, respectively. At 1 year, the mean values decreased significantly to 2.59 ± 1.06 μm, 2.42 ± 1.07 μm, 2.39 ± 1.07 μm, 0.88 ± 0.49 μm, and 0.83 ± 0.38 μm, respectively (all P=.01). After CXL, HOAs were significantly improved compared with the control group. Changes in HOAs were not statistically associated with an improvement in visual acuity or most subjective visual symptoms, however. CONCLUSION: Corneal and ocular HOAs decreased after CXL, suggesting an improvement in corneal shape.
Authors: Rohit Shetty; Rudy M M A Nuijts; Purnima Srivatsa; Chaitra Jayadev; Natasha Pahuja; Mukunda C Akkali; Abhijit Sinha Roy Journal: Biomed Res Int Date: 2015-04-06 Impact factor: 3.411
Authors: Bence Lajos Kolozsvári; András Berta; Goran Petrovski; Kata Miháltz; Péter Gogolák; Eva Rajnavölgyi; Ziad Hassan; Péter Széles; Mariann Fodor Journal: PLoS One Date: 2013-10-04 Impact factor: 3.240